about
Neurofilament light chain: a biomarker for genetic frontotemporal dementiaNeurofilament light chain predicts disease activity in relapsing-remitting MS.Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis.Serum neurofilament light chain in patients with acute cerebrovascular events.Serum neurofilament light chain: a biomarker of neuronal injury in vasculitic neuropathy.Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum.Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.Neurofilament as Neuronal Injury Blood Marker in Preeclampsia.Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic strokeNfL is a biomarker for adult-onset leukoencephalopathy with axonal spheroids and pigmented gliaSerum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosisNeurofilament Light Chain: Blood Biomarker of Neonatal Neuronal InjuryLongitudinal MRI dynamics of recent small subcortical infarcts and possible predictorsSerum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s diseaseBlood neurofilament light as a potential endpoint in Phase 2 studies in MS.Neurofilament Light Chain Determination from Peripheral Blood SamplesSerum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosisNeurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosisSerum glial fibrillary acidic protein correlates with multiple sclerosis disease severitySerum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year studyNeurofilament light levels are associated with long-term outcomes in multiple sclerosisImpact of parturition on maternal cardiovascular and neuronal integrity in a high risk cohort - a prospective cohort studyNeurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosisMonitoring of radiologic disease activity by serum neurofilaments in MSSerum neurofilament light chain as a prognostic marker in postanoxic encephalopathySerum neurofilament light chain in pediatric MS and other acquired demyelinating syndromesAssociation Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 YearsSerum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal studySerum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosisSerum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSDSerum neurofilament light chain in chronic inflammatory demyelinating polyneuropathyNeurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort studyCorrelations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approachesSerum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
P50
Q37208495-466F53B1-C177-43E2-8209-BD789A6B95A6Q47138197-2B2B2969-39F2-44E5-85AD-055DF2CA405EQ47929450-7EE7A683-A5DA-4024-9FD5-3CD5DC9384B5Q48343364-DCFA29E0-068C-49E1-916B-279004AAFA2BQ48347465-0B311720-0550-4637-ADE5-10709796B8C5Q48730030-C401ECD2-9468-40E5-95EC-4DA59932DAF1Q49015259-D56098F2-508E-47AC-BA8B-555029401E43Q54980322-3A124E13-420C-4C5A-AE2B-49012DD8506BQ57049032-CA706DD9-7EBD-447C-8ADE-074F2AA3053BQ57459513-EDE6633E-FA2D-4ABC-A865-EA0541FCDE0CQ57623408-799753E0-82B7-47A2-B11C-B6404ECE410BQ59791789-8410ED8C-8351-4589-9EDE-9D72A94937D6Q59847247-A69DC36C-C08C-4425-B165-021D7239D098Q60961744-9397356D-66A1-42D9-860A-48042936DBEFQ64970888-61D255A7-DE02-4C8C-B4B1-BBE57DC51020Q86748852-ECD1D6DE-63AE-465F-BD3E-1EEE43407B33Q88960884-2E45270A-2812-441E-8E7B-92ABF1F799C4Q90625135-019564C8-2371-45C8-AB8F-6384A7A9BC56Q90662999-A2A70A0D-54AC-4E11-8B47-48A79FF2FDF0Q90698412-8D0518C9-E091-4909-8E5A-312A6C58D739Q91080297-5D17AE49-FF0F-4023-99FE-FB5A795BB6D6Q91127760-AD764951-FC14-456B-9C63-2E822A47477AQ91627225-E9E4A1AE-8EFA-488B-99E0-D57A0FC5F424Q91787196-DDD61B76-459D-42F9-96DE-6EB4BD8ABB12Q92375451-40583E48-2A04-4236-AF99-4FBFC909E246Q92431236-012441BB-7CFD-481B-B91B-954F94AC58FBQ92561435-1AFDBE83-29F0-4EC7-9FE2-D5E5AB6ABB2DQ92774722-1F7839B9-DA8F-4F44-B8AE-DD6E72DA2049Q92797744-2727504B-1CF6-4F25-B80E-727EF5D1DAA0Q93022960-9E9888A7-309D-4106-AAF2-F4879B6A066CQ93024367-364E5480-0FDB-4A3C-802F-C98FDE74C444Q93053879-C69A0F15-62FC-465A-8ECC-F8DAF2A098B8Q93103206-EB447A68-31D5-4D6C-B9C2-F58B3FEA0605Q94669964-59B84B51-BCBF-4F01-9EA8-18A4B73CC7A5
P50
description
researcher ORCID ID = 0000-0002-7795-7383
@en
wetenschapper
@nl
name
Christian Barro
@ast
Christian Barro
@en
Christian Barro
@es
Christian Barro
@nl
type
label
Christian Barro
@ast
Christian Barro
@en
Christian Barro
@es
Christian Barro
@nl
prefLabel
Christian Barro
@ast
Christian Barro
@en
Christian Barro
@es
Christian Barro
@nl
P106
P21
P31
P496
0000-0002-7795-7383